Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix S Lichtenegger

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|June 27, 2015
Immunotherapy for Acute Myeloid LeukemiaFelix S Lichtenegger, Christina Krupka, Thomas Köhnke, et al.
Immunotherapy|December 22, 2012
Current strategies in immunotherapy for acute myeloid leukemiaFelix S Lichtenegger, Frauke M Schnorfeil, Wolfgang Hiddemann, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2021
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigensGerulf Hänel, Caroline Angerer, Katja Petry, et al.
Journal of Hematology & Oncology|July 27, 2017
Recent developments in immunotherapy of acute myeloid leukemiaFelix S Lichtenegger, Christina Krupka, Sascha Haubner, et al.
Leukemia Research|June 25, 2014
Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AMLFelix S Lichtenegger, Robin Lorenz, Katharina Gellhaus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Dissociation of experimental allergic encephalomyelitis protective effect and allergic side reactions in tolerization with neuroantigenFelix S Lichtenegger, Stefanie Kuerten, Susan Faas, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemiaMarion Subklewe, Christiane Geiger, Felix S Lichtenegger, et al.
Plos One|September 11, 2012
CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cellsFelix S Lichtenegger, Katharina Mueller, Bettina Otte, et al.
Journal of Neuroimmunology|June 20, 2006
MBP-PLP fusion protein-induced EAE in C57BL/6 miceStefanie Kuerten, Felix S Lichtenegger, Susan Faas, et al.
Journal of Translational Medicine|September 14, 2011
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remissionBarbara Beck, Daniela Dörfel, Felix S Lichtenegger, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|June 27, 2015
Immunotherapy for Acute Myeloid LeukemiaFelix S Lichtenegger, Christina Krupka, Thomas Köhnke, et al.
Immunotherapy|December 22, 2012
Current strategies in immunotherapy for acute myeloid leukemiaFelix S Lichtenegger, Frauke M Schnorfeil, Wolfgang Hiddemann, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2021
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigensGerulf Hänel, Caroline Angerer, Katja Petry, et al.
Journal of Hematology & Oncology|July 27, 2017
Recent developments in immunotherapy of acute myeloid leukemiaFelix S Lichtenegger, Christina Krupka, Sascha Haubner, et al.
Leukemia Research|June 25, 2014
Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AMLFelix S Lichtenegger, Robin Lorenz, Katharina Gellhaus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Dissociation of experimental allergic encephalomyelitis protective effect and allergic side reactions in tolerization with neuroantigenFelix S Lichtenegger, Stefanie Kuerten, Susan Faas, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemiaMarion Subklewe, Christiane Geiger, Felix S Lichtenegger, et al.
Plos One|September 11, 2012
CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cellsFelix S Lichtenegger, Katharina Mueller, Bettina Otte, et al.
Journal of Neuroimmunology|June 20, 2006
MBP-PLP fusion protein-induced EAE in C57BL/6 miceStefanie Kuerten, Felix S Lichtenegger, Susan Faas, et al.
Journal of Translational Medicine|September 14, 2011
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remissionBarbara Beck, Daniela Dörfel, Felix S Lichtenegger, et al.
Pageof 3